2019 Cannabis Business Award's Publication of the Year |
WEDNESDAY, DECEMBER 13, 2023 |
FMCPG HAS BEEN SERVING AND REPRESENTING THE CANNABIS PHYSICIAN COMMUNITY SINCE 2020 |
REGISTER FOR NEXT MEETING WEDNESDAY,JANUARY 10, 2024 AT 6:30PM THE "FLORIDA MEDICAL CANNABIS
PHYSICIAN GROUP" (FMCPG) FOR ALL "MEDICAL MARIJUANA DOCTORS"
AND "MMTC DIRECTORS ONLY " TOPICS TO BE DISCUSSED REVIEW OF OUR "2024 LEGISLATIVE PRIORITIES" FOR PRESENTATION IN TALLAHASSEE AND
UPDATE FROM MEETINGS WITH LEGISLATORS IN TALLAHASSEE UPDATES ON RFE REQUESTS PROTECTING YOUR MEDICAL CANNABIS PRACTICE
QUESTIONS FROM PHYSICIANS HOW TO BEST ANSWER YOUR PATIENT QUESTIONS
Becoming a Chapter of the Society of Cannabis Clinicians (If you are currently a member, and have not sent me an email, please send me an email today) |
MEDICAL CANNABIS PHYSICIAN
PROMOTION PACKAGE BY CANNABIS NEWS FLORIDA ARTICLE: Physician will contribute an article of 350 words**. This article will appear in the Cannabis News Florida e-newsletter for one month (4 weeks).
E-MAIL BLAST: Cannabis News Florida will send out one e-mail blast promoting the Physician to the other physicians in three zip code areas or one city to be determined by the Physician. The Physician will supply the information for the email blast. The Article above can be used in the e-mail blast.
The cost of this program is ONLY $500.
**Cannabis News Florida will assign a writer for a telephone interview with the Physician and create the article to be published. Physician shall have the right to review and approve the article before publication for an additional cost of $100.
IF YOU ARE INTERESTED, PLEASE EMAIL ME AT CHARLES@CANNABISNEWSFLORIDA.COM OR CALL MY CELL AT 954-605-4785 |
NEWS FROM THE PAST WEEK RELATING TO THE BUSINESS OF
MMTC'S IN FLORIDA
Click on Company Logo to be Transferred to Web Site |
THE CANNABIST COMPANY CELEBRATES APPROVAL OF ADULT-USE WHOLESALE DISTRIBUTION AND RETAIL SALES IN NEW YORK
The Company Will Commence Adult-Use Wholesale Deliveries in New York with Products from Riverhead and Rochester Cultivation Facilities Available to Active Retail Locations throughout the State
NEW YORK, December 8, 2023 – The Cannabist Company Holdings Inc. (NEO: CBST) (OTCQX: CBSTF) (FSE: 3LP) (“The Cannabist Company” or the “Company”), one of the largest and most experienced cultivators, manufacturers, and retailers of cannabis products in the U.S., announced today it has been approved by the New York Office of Cannabis Management for adult-use wholesale distribution, which will commence immediately, and adult-use retail sales, which the Company has the option to begin at a later date upon payment of the required fees. The Cannabist Company’s popular brands including Seed & Strain and Hedy edibles will be available to both existing and newly approved adult-use dispensaries across the state, with its first sale to Herbal IQ, a retailer with five locations near Buffalo and Rochester. Additional brands will launch in the coming months, pending regulatory approval.
“After more than a decade of serving the New York medical market, the day has finally arrived for us to capitalize on the tremendous assets we have built and to begin bringing trusted, tested products to the growing adult-use market. New York is the cannabis capital of the East Coast, and we are thrilled to be supplying our partners with high-quality products as the industry reaches a new milestone with the further implementation of adult-use sales,” said Nicholas Vita, CEO, The Cannabist Company. “New York is going to rapidly become the largest cannabis market in the country, and we are ready to supply that growing demand from our scaled cultivation and manufacturing facilities in Long Island and Rochester, with premium and enjoyable products. As we begin to launch our wholesale partnerships across the state, we will concurrently evaluate and plan for the opening of our first adult use retail location in New York City.”
READ MORE |
THE COMPANY’S SELECT AND GRASSROOTS BRANDS ARE NOW AVAILABLE AT LEGAL ADULT USE DISPENSARIES IN THE EMPIRE STATE
December 12, 2023 — Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading international provider of consumer cannabis products, today announced that it has commenced sales of wholesale adult use products across the state of New York as a result of receiving approval from the New York State Office of Cannabis Management (“OCM”) on Friday, December 8.
As of December 12, Curaleaf will offer five premium vape, edible and flower offerings from its Select and Grassroots brand portfolios, including Select Briq Essentials, Select X Bites, Select Nano Bites and Grassroots premium flower. The Company’s wholesale partners include MJ Dispensary, a CAURD licensee which will include Curaleaf products as a part of its Grand Opening event at 4:20 pm ET today, December 12 at 900 Jefferson Rd Suite 902. Rochester, NY. Future products will be produced using local New York-grown flower, including distillate from New York based hemp farm Open Mind Organics (OMO). Led by David Falkowski, a third generation farmer who became one of the first licensed hemp farmers in the state, this year OMO solidified its position as one of the leading adult use cultivators and processors for cannabis in New York.
READ MORE |
GREEN THUMB ANNOUNCES RETIREMENT OF RICHARD DREXLER FROM BOARD OF DIRECTORS
CHICAGO and VANCOUVER, British Columbia, December 08, 2023 — Green Thumb Industries Inc. (“Green Thumb” or the “Company”) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company and owner of RISE Dispensaries, today announced the retirement of Richard Drexler from its Board of Directors (the “Board”), effective December 8. Drexler joined Green Thumb’s Board in 2022 and served as Chair of the Audit Committee. Following his departure, Richard Reisin will assume the role of Chair of the Audit Committee. Drexler will continue to support the Board in a short-term consultant role to ensure a smooth transition.
READ MORE |
PLANET 13 ENTERS INTO SETTLEMENT AGREEMENT
November 14, 2023 / Planet 13 Holdings Inc. (CSE:PLTH)(OTCQX:PLNH) (“Planet 13” or the “Company“), a leading vertically-integrated multi-state cannabis company, today announced that it has entered into a settlement agreement on November 14, 2023 (the “Settlement Agreement“) with certain individuals (collectively, the “SDC Parties“) with respect to certain claims (collectively, the “Legal Actions“) advanced by the SDC Parties against Next Green Wave Holdings, Inc. (“NGW“), a subsidiary of NGW and the Company (collectively, the “Planet 13 Parties“). As a result of the Company’s acquisition of NGW on March 2, 2022, the Company assumed all liabilities of NGW.
Pursuant to the Settlement Agreement, in consideration for the SDC Parties releasing the Planet 13 Parties from claims relating to the Legal Actions and to avoid the further expense of litigation, the Company agreed to pay the SDC Parties a cash payment of US$300,000 in the aggregate (the “Cash Payment“) and issue the SDC Parties an aggregate of 1,000,000 shares of common stock in the capital of the Company (the “Settlement Shares“). The Cash Payment will be made and the Settlement Shares will be issued on the date that is 14 days from the date of signing of the Settlement Agreement. Based on the closing price of the Company’s shares of common stock on the Canadian Securities Exchange of CAD$1.2000 and based on the Bank of Canada’s CAD to USD exchange rate of US$1.00=CAD$1.3725, in each case as of November 14, 2023, the total settlement amount is approximately US$1,174,316.94. The Settlement Shares will be subject to resale restrictions under applicable U.S. and Canadian securities laws.
READ MORE |
NATIONAL AND INTERNATIONAL NEWS |
STUDY RESULTS OF PSILOCYBIN TREATMENT IN BIPOLAR II DEPRESSION PUBLISHED IN JAMA PSYCHIATRY
BELIEVED TO BE FIRST EVER PSILOCYBIN CLINICAL TRIAL FOR TREATMENT OF BIPOLAR II DEPRESSION
LONDON, Dec. 06, 2023 — Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the publication of a paper in
JAMA Psychiatry that demonstrates the potential for investigational COMP360 psilocybin treatment in treatment-resistant bipolar type II disorder (bipolar II). Results from the investigator-initiated open-label study were first presented at the Annual Meeting of the American College of Neuropsychopharmacology in 2022.
The study, which was conducted by Dr Scott Aaronson at Sheppard Pratt, Baltimore, and funded by Compass, investigated the safety and efficacy of a single 25mg dose of COMP360 psilocybin treatment in participants with treatment-resistant bipolar II. The primary endpoint was change in Montgomery-Åsberg Depression Rating Scale (MADRS) total score from baseline to week 3. All participants (n = 15) had lower MADRS scores with a mean change from baseline of -24.0 points at week 3, 12 participants met the response criteria and 11 met the remission criteria.
READ MORE |
DAG, A CEA FACILITIES INDUSTRY LEADER, ANNOUNCES COMPLETION OF 13,000-SQUARE-FOOT HAMILTON FARMS FACILITY IN MILLVILLE, NEW JERSEY
DAG and Hamilton Farms Celebrated the Facility’s Completion at a Grand Opening Event
CORAL GABLES, FLA. December 7, 2023 – DAG, an industry leader in the planning, design and construction of Controlled Environment Agriculture (CEA) facilities for the Cannabis and produce industries, is pleased to announce its completion of a 13,000-square-foot facility for Hamilton Farms in Millville, New Jersey. Hamilton Farms is a craft cultivator delivering high-quality Cannabis to the New Jersey adult-use market.
DAG CEO Mark Gemignani and Director of Architecture and Engineering Jeff Lair attended the grand opening and ribbon-cutting event for the facility, which is ready to begin operations.
After verifying the building’s suitability (it was previously a warehouse), DAG gutted and renovated the entire space for optimal configuration to allow the production of high-quality craft Cannabis. DAG led execution of design and construction, and integration of all specialty vendors, consultants, and subcontractors.
READ MORE |
SPRINGBIG LAUNCHES “GIFT CARDS BY SPRINGBIG”, TRANSFORMING PAYMENT SOLUTIONS FOR THE CANNABIS RETAIL EXPERIENCE
The new gift card feature is the latest product launch on the Springbig platform to streamline payments and meet evolving consumer preferences.
BOCA RATON, Fla., Nov. 20, 2023 — SpringBig Holdings, Inc. (OTCQX: SBIG), a leading provider of vertical SaaS-based marketing solutions, today announced the launch of Gift Cards by Springbig. The new feature builds on recent product launches across the platform to revolutionize the way customers engage with retailers through secure, user-friendly, and efficient payment solutions. Springbig is paving the way for a future where dispensary transactions are easier and more convenient than ever.
Both physical and digital gift cards are a growing category among consumers of all ages. Seventy six percent of consumers have purchased a gift card in the past year, and of those gift cards purchased, 40 percent were digital. Additionally, 61 percent of consumers reported spending more than the amount included on the card when redeeming, boosting total sales for merchants.
READ MORE |
CHRISTINA LAKE CANNABIS PROVIDES HARVEST UPDATE
VANCOUVER, British Columbia, Dec. 06, 2023 — Christina Lake Cannabis Corp. (CSE: CLC) (OTCQB: CLCFF) (FRANKFURT:CLB), (the “Company” or “Christina Lake Cannabis” or “CLC”), a leading producer of high quality extracts and sun grown cannabis, is pleased to announce its fourth consecutive successful outdoor harvest.
The 2023 harvest yielded more than 37,000 kg of dry outdoor flower and biomass. The flower and biomass is expected to be processed to create multiple product offerings such as flower, kief, hash and distillate, all of which are highly sought after ingredients that are critical components to the production of finished goods by our customers. These finished goods take the forms of packaged flower, vapes, pre-rolls, infused pre-rolls, hash, edibles and beverages under many of the top brands in the Canadian cannabis market. To support the growing customer demand for diversified products, our cultivation team has continued to develop inhouse genetics through a breeding program that has led the company to be able to increase allocation towards high quality outdoor flower, kief, and hash, expanding the product mix and improving CLCs ability to be a key supplier to top brands.
READ MORE |
UNRIVALED BRANDS REPORTS AVERAGE 96% CONSOLIDATED STOCKHOLDER VOTING SUPPORT
SANTA ANA, Calif., December 06, 2023 — Unrivaled Brands, Inc. (OTCQB: UNRV) (“Unrivaled,” “Unrivaled Brands,” “Company,” “we” or “us”), a cannabis company with operations throughout California, is pleased to announce the successful outcome of its 2023 annual meeting of Stockholders held on December 5, 2023 (“Annual Meeting”), which was conducted via telecast.
At the Annual Meeting, stockholders demonstrated overwhelming support for key proposals, reflecting their confidence in the Company’s direction and leadership. The following proposals were approved by the stockholders:
1. The proposal to approve and adopt the Agreement and Plan of Merger, dated October 9, 2023, by and among the Company, Blum Holdings, Inc., a newly formed Delaware corporation (“Blüm”), and Blum Merger Sub, Inc., which provides for our reorganization into a Delaware holding company, with the Company becoming a wholly owned subsidiary of Blüm and the current stockholders of the Company becoming stockholders of Blüm (the “Reorganization”).
2. The proposal to approve the amendment of our articles of incorporation to effect a reverse stock split of all outstanding shares of our common stock at an exchange ratio between 1-for-70 to 1-for-100, with the exact ratio to be determined by our Board of Directors (the “Board”) in its discretion.
READ MORE |
22ND CENTURY SECURES $3.2 MILLION TO DATE IN WARRANT EXCHANGE TRANSACTION
Newly Appointed CEO Leading Restructuring to Focus on Tobacco Industry Operations, Reduce Costs
BUFFALO, N.Y., December 04, 2023 — 22nd Century Group, Inc. (Nasdaq: XXII) (the “Company”), a biotechnology company focused on utilizing advanced plant technologies to improve health and wellness, today announced the exercise of warrants by certain holders pursuant to its previously announced warrant inducement offering. During the inducement period, certain holders of the Company’s existing warrants acquired an aggregate of 14,767,386 shares of common stock upon exercise of their existing warrants at a reduced exercise price of $0.215. To date, the Company has received aggregate gross proceeds of approximately $3.2 million from the exercise of the existing warrants, before deducting placement agent’s fees and other offering expenses payable by the Company. The Company expects to use the net proceeds of the offering for general corporate purposes.
“This warrant transaction provides important operating capital for 22nd Century which, in conjunction with our ongoing restructuring activities, will support our tobacco operations into next year,” said Larry Firestone, newly appointed Chairman and Chief Executive Officer. “The team is already working to swiftly improve the performance of our conventional tobacco manufacturing business, FDA authorized tobacco harm reduction products and extensive IP portfolio, with a goal of substantially reducing operating costs and putting the business on a new path to sustainable revenue performance and cash positive operations. We believe that our strategies for the core tobacco business will enhance value for shareholders.”
READ MORE |
BELOW ARE THE LINKS TO THE DIRECTORY OF FLORIDA CANNABIS DOCTORS AND
DISPENSARIES IN THE STATE OF FLORIDA |
QUALIFIED PATIENTS OVER 862,000 AND 610 DISPENSING LOCATIONS
|
LATEST OMMU REPORTS FROM OFFICE OF MEDICAL MARIJUANA USE IN THE STATE OF FLORIDA Highlights from
DECEMBER 8, 2023 Report
BY THE NUMBERS Qualified Patients: (Active ID Card):
DEC 08 2023- 862,824 DEC 01 2023- 862,155 NOV 24 2023- 859,125
NOV 17 2023- 859,524 NOV 13 2023- 855,965 Patients Last Week: 669
Qualified Ordering Physicians: 2,740
New Doctors Last Week: +2 Reporting Period: DEC 1 TO DEC 7 2023 Amount of Medical Marijuana Dispensed - (mgs THC) 295,934,878
Amount of Low-THC Cannabis Dispensed - (mgs CBD) 2,726,019
Amount of Marijuana in a From for Smoking (oz) 105,837.064 Approved Dispensing Locations: 610 ADD LAST WEEK 2
AYR CANNABIS - LEESBURG GTI ( RISE ) - PORT ORANGE |
UPCOMING MEETING AND CONFERENCES |
Integrative Mental Health Intensive Workshop
In Person in Boca Raton, FL & Available Online January 20th-21st 2024 9:00 AM – 4:00 PM
Join clinician Shari B. Kaplan, LCSW for a two- day CME accredited workshop providing an in-depth approach to best practices for integrative mental health. Kaplan will educate on her integrative approach from assessments, treatment plans and process. She begins with a thorough psychosocial assessment (this includes Bio-psychosocial assessment, family attachments/dynamics, medical history, spiritual beliefs, exercise, nutrition, relationships, strengths/deficits) to have an in depth understanding of patient, prepare for treatment and create treatment goals.
She will share when and how to use plant medicine and cannabis as natural approaches in treatment both with and without conventional medicine. Kaplan will demonstrate techniques for applying focused work using modalities like EMDR, IFS, ego state work, CBT and Functional Spirituality. (EMDR & IFS are demonstrated in how they are applied).
Attendees will learn strategies in the 'process phase' on teaching self-regulation, behavior change skills to assist patients in their daily lives and how to interweave movement & music. Kaplan will additionally explore ways to leverage microdosing of cannabis and other plant medicine, alongside with lifestyle changes, and adjunctive therapies (nutrition, exercise, meditation, mindfulness, breath work, acupuncture/body work) to maintain therapeutic momentum during and outside of treatment, assisting patients in improving the quality of their lives. This dynamic workshop provides clinicians with an integrative mental health approach to treatment. Both with and without psychedelic assisted therapy.
Cost $895.00
Call to RSVP 561-346-3169 or Email us at Info@cannectd.com Limited Availability |
ADVERTISEMENT OPPORTUNITIES
If your goal is to get your business in front of the right people in the cannabis industry or you want to be an integral part of this new and exciting business opportunity, then you need to join with Cannabis News Florida as we help to establish cannabis as a major part of the economy in Florida. Cannabis News Florida is an online publication focusing on both local and national news from leading authorities about the medical and business developments in the medical cannabis industry covering the entire state of Florida.
Join the Cannabis News Florida force online and in print. We offer several marketing options to fit all budgets:
· MMTC PROMOS LISTED IN EACH E-NEWSLETTER
• Directory Listing
• Banner Ads
• Ad Space in the Newspaper
• Feature Articles
• Weekly Newsletters
For further information or to make your ad reservation, please call:561-368-6950 / 954-605-4785 cell charles@cannabisnewsflorida.com
|
|
|